scispace - formally typeset
M

Michael Hauptmann

Researcher at Netherlands Cancer Institute

Publications -  210
Citations -  11957

Michael Hauptmann is an academic researcher from Netherlands Cancer Institute. The author has contributed to research in topics: Breast cancer & Cancer. The author has an hindex of 54, co-authored 203 publications receiving 10189 citations. Previous affiliations of Michael Hauptmann include National Institutes of Health & United States Department of Health and Human Services.

Papers
More filters
Journal ArticleDOI

A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.

TL;DR: Assessment of PI3K pathway activation may provide a biomarker to identify patients unlikely to respond to trastuzumab-based therapy, and the combined analysis of PTEN and PIK3CA identified twice as many patients at increased risk for progression compared to PTEN alone.
Journal ArticleDOI

Refinement of breast cancer classification by molecular characterization of histological special types.

TL;DR: The results imply that the correct classification of breast cancers of special histological type will allow a more accurate prognostication of breast cancer patients and facilitate the identification of optimal therapeutic strategies.
Journal ArticleDOI

Risk of Cataract after Exposure to Low Doses of Ionizing Radiation: A 20-Year Prospective Cohort Study among US Radiologic Technologists

TL;DR: Findings challenge the National Council on Radiation Protection and International Commission on Radiological Protection assumptions that the lowest cumulative ionizing radiation dose to the lens of the eye that can produce a progressive cataract is approximately 2 Gy and support the hypothesis that the highest cataracts produced in humans is substantially less than previously thought.
Journal ArticleDOI

Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma

TL;DR: The linear radiation dose-response relationship identified can be used to predictCHD risk for future HL patients and survivors and Appropriate early management of CHD risk factors and stimulation of physical activity may reduce CHDrisk in HL survivors.
Journal ArticleDOI

Mortality from Solid Cancers among Workers in Formaldehyde Industries

TL;DR: In this cohort of formaldehyde-industry workers, some evidence was found of an exposure-response relation with mortality from nasopharyngeal cancer (based on small numbers) but not for cancers of the pancreas, brain, lung, or prostate.